[go: up one dir, main page]

MX2016007057A - Administracion y monitoreo de oxido nitrico en fluidos ex vivo. - Google Patents

Administracion y monitoreo de oxido nitrico en fluidos ex vivo.

Info

Publication number
MX2016007057A
MX2016007057A MX2016007057A MX2016007057A MX2016007057A MX 2016007057 A MX2016007057 A MX 2016007057A MX 2016007057 A MX2016007057 A MX 2016007057A MX 2016007057 A MX2016007057 A MX 2016007057A MX 2016007057 A MX2016007057 A MX 2016007057A
Authority
MX
Mexico
Prior art keywords
nitric oxide
administration
monitoring
fluids
fluid
Prior art date
Application number
MX2016007057A
Other languages
English (en)
Other versions
MX381625B (es
Inventor
Potenziano Jim
R Hansell Douglas
Griebel Jeff
COSTA Eddie
Cooper Lisa
Original Assignee
Mallinckrodt Hospital Products Ip Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mallinckrodt Hospital Products Ip Ltd filed Critical Mallinckrodt Hospital Products Ip Ltd
Publication of MX2016007057A publication Critical patent/MX2016007057A/es
Publication of MX381625B publication Critical patent/MX381625B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N1/00—Preservation of bodies of humans or animals, or parts thereof
    • A01N1/10—Preservation of living parts
    • A01N1/12—Chemical aspects of preservation
    • A01N1/122—Preservation or perfusion media
    • A01N1/126—Physiologically active agents, e.g. antioxidants or nutrients
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N1/00—Preservation of bodies of humans or animals, or parts thereof
    • A01N1/10—Preservation of living parts
    • A01N1/14—Mechanical aspects of preservation; Apparatus or containers therefor
    • A01N1/142—Apparatus
    • A01N1/143—Apparatus for organ perfusion
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/36—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
    • A61M1/3621—Extra-corporeal blood circuits
    • A61M1/3623—Means for actively controlling temperature of blood
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0634—Cells from the blood or the immune system
    • C12N5/0641—Erythrocytes
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N1/00—Preservation of bodies of humans or animals, or parts thereof
    • A01N1/10—Preservation of living parts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/14—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M16/00—Devices for influencing the respiratory system of patients by gas treatment, e.g. ventilators; Tracheal tubes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Dentistry (AREA)
  • Environmental Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • Anesthesiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Cardiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Biophysics (AREA)
  • Physiology (AREA)
  • External Artificial Organs (AREA)
  • Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)

Abstract

La presente invención se refiere a sistemas y métodos para monitorear la administración de óxido nítrico (NO) a fluidos ex vivo. Ejemplos de tales fluidos incluyen sangre en los circuitos de oxigenación de membrana extracorporal (ECMO) o fluidos de perfusión usados para preservar órganos ex vivo previo al transplante en un recipiente. Los sistemas y métodos descritos en la presente se proporcionan para administrar óxido nítrico al fluido, monitorear óxido nítrico o un marcador de óxido nítrico en el fluido, y ajustar la administración de óxido nítrico.
MX2016007057A 2013-03-15 2014-12-01 Administración y monitoreo de óxido nítrico en fluidos ex vivo. MX381625B (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361787865P 2013-03-15 2013-03-15
US14/095,621 US9629358B2 (en) 2013-03-15 2013-12-03 Administration and monitoring of nitric oxide in ex vivo fluids
PCT/US2014/067856 WO2015084698A2 (en) 2013-03-15 2014-12-01 Administration and monitoring of nitric oxide in ex vivo fluids

Publications (2)

Publication Number Publication Date
MX2016007057A true MX2016007057A (es) 2017-02-02
MX381625B MX381625B (es) 2025-03-12

Family

ID=51528684

Family Applications (2)

Application Number Title Priority Date Filing Date
MX2016007057A MX381625B (es) 2013-03-15 2014-12-01 Administración y monitoreo de óxido nítrico en fluidos ex vivo.
MX2021001867A MX2021001867A (es) 2013-03-15 2016-05-31 Administracion y monitoreo de oxidio nitrico en fluidos ex vivo.

Family Applications After (1)

Application Number Title Priority Date Filing Date
MX2021001867A MX2021001867A (es) 2013-03-15 2016-05-31 Administracion y monitoreo de oxidio nitrico en fluidos ex vivo.

Country Status (12)

Country Link
US (3) US9629358B2 (es)
EP (2) EP3086638B1 (es)
JP (2) JP6612231B2 (es)
AU (3) AU2014357412B2 (es)
CA (3) CA3135254C (es)
DK (1) DK3698630T3 (es)
ES (1) ES2805366T3 (es)
FI (1) FI3698630T3 (es)
MX (2) MX381625B (es)
PL (1) PL3698630T3 (es)
PT (1) PT3698630T (es)
WO (1) WO2015084698A2 (es)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ554543A (en) 2004-10-07 2011-03-31 Transmedics Inc Systems for ex-vivo organ care
US12010987B2 (en) 2004-10-07 2024-06-18 Transmedics, Inc. Systems and methods for ex-vivo organ care and for using lactate as an indication of donor organ status
US9078428B2 (en) 2005-06-28 2015-07-14 Transmedics, Inc. Systems, methods, compositions and solutions for perfusing an organ
US9457179B2 (en) 2007-03-20 2016-10-04 Transmedics, Inc. Systems for monitoring and applying electrical currents in an organ perfusion system
US8420380B2 (en) 2008-01-31 2013-04-16 Transmedics, Inc. Systems and methods for ex vivo lung care
CN109997836B (zh) 2011-04-14 2022-02-08 特兰斯迈迪茨公司 用于供体肺的离体机器灌注的器官护理溶液
JP2017518301A (ja) 2014-06-02 2017-07-06 トランスメディクス， インク．Ｔｒａｎｓｍｅｄｉｃｓ， Ｉｎｃ． ｅｘ−ｖｉｖｏでの臓器管理システム
US11083191B2 (en) 2014-12-12 2021-08-10 Tevosol, Inc. Apparatus and method for organ perfusion
JP6934005B2 (ja) 2015-09-09 2021-09-08 トランスメディクス，インコーポレイテッド エキソビボ臓器管理システムのための大動脈カニューレ
EP3386574A4 (en) * 2015-12-11 2019-07-17 Vero Biotech LLC METHOD AND APPARATUS FOR GAS ADMINISTRATION COMPRISING NITRIC OXIDE FOR TREATING FIBROSIS
AU2017218391B2 (en) 2016-02-12 2022-11-24 Mallinckrodt Pharmaceuticals Ireland Limited Use and monitoring of inhaled nitric oxide with left ventricular assist devices
DK3462861T5 (da) 2016-05-30 2024-01-08 Transmedics Inc Fremgangsmåde til ex vivo-lungeventilati on med et varierende udvendigt tryk
EP3509684A4 (en) * 2016-09-10 2020-10-21 Vero Biotech LLC PORTABLE NITRIC OXIDE ADMINISTRATION SYSTEM AND METHOD
TWI656890B (zh) * 2017-07-12 2019-04-21 英屬開曼群島商怡忠國際有限公司 體外生命支持系統
AU2018322317B2 (en) * 2017-08-25 2023-11-23 Mallinckrodt Pharmaceuticals Ireland Limited Methods to improve organ viability
US11881119B2 (en) * 2017-12-06 2024-01-23 Cilag Gmbh International Modeling air leaks in lungs
GB2587350B (en) * 2019-09-23 2021-12-15 Royal Papworth Hospital Nhs Found Trust Organ perfusion system and method
WO2021177164A1 (ja) * 2020-03-05 2021-09-10 テルモ株式会社 医療デバイス
GB2596041B (en) * 2020-03-26 2024-12-04 Univ Newcastle System and Method for Monitoring Body Tissue
CN113797404B (zh) * 2021-01-06 2023-05-09 郝云玲 一种向血液中补充一氧化氮（no）的装置
EP4137170A1 (en) 2021-07-29 2023-02-22 Tim Bast Purge fluid generator for membrane oxygenation
CN113975505B (zh) * 2021-11-08 2023-12-19 中山大学中山眼科中心 用于眼球灌注的体外循环系统
US12128166B2 (en) 2022-12-16 2024-10-29 Fresenius Medical Care Holdings, Inc. Systems and methods for using nitric oxide in dialysis
US12357533B2 (en) * 2023-08-25 2025-07-15 Paragonix Technologies, Inc. Systems and methods for maintaining organ pressure
WO2025213152A1 (en) * 2024-04-06 2025-10-09 The Board Of Trustees Of The Leland Stanford Junior University Cardiac ex vivo preservation system compatible for use with any oxygenator and pump

Family Cites Families (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5338662A (en) 1992-09-21 1994-08-16 Bio-Preserve Medical Corporation Organ perfusion device
US5558083A (en) 1993-11-22 1996-09-24 Ohmeda Inc. Nitric oxide delivery system
US5725492A (en) * 1996-03-04 1998-03-10 Cormedics Corp Extracorporeal circulation apparatus and method
EP1712226A3 (en) * 1996-04-05 2007-03-21 The General Hospital Corporation Treatment of a Hemoglobinopathy
US5732693A (en) 1996-10-02 1998-03-31 Ohmeda Inc. Pause control of nitric oxide therapy
US5752504A (en) 1996-12-13 1998-05-19 Ohmeda Inc. System for monitoring therapy during calibration
US5885842A (en) * 1996-11-08 1999-03-23 Medinox, Inc. Methods for the detection of nitric oxide in fluid media
US6125846A (en) 1997-05-16 2000-10-03 Datex-Ohmeda, Inc. Purge system for nitric oxide administration apparatus
US7749693B2 (en) * 1998-09-29 2010-07-06 Lifeline Scientific, Inc. Method of determining that an organ is not suitable for transplantation and using it for testing substances
GB9908335D0 (en) * 1999-04-12 1999-06-09 Univ Cambridge Tech Methods and means for extracorporeal organ perfusion
US6314956B1 (en) * 1999-09-08 2001-11-13 Duke University Pulmonary delivery of NO group-containing compound in gas form to treat respiratory, cardiac and blood disorders
JP4258908B2 (ja) * 1999-09-14 2009-04-30 株式会社ジェイ・エム・エス 人工肺装置
JP2001178817A (ja) * 1999-12-24 2001-07-03 Terumo Corp 人工腎臓用装置およびこれを用いた品質評価装置ならびに流体回路
US7122018B2 (en) * 2000-12-26 2006-10-17 Sensormedics Corporation Device and method for treatment of wounds with nitric oxide
US6501974B2 (en) * 2001-01-22 2002-12-31 Datex-Ohmeda, Inc. Compensation of human variability in pulse oximetry
PL367544A1 (en) 2001-06-21 2005-02-21 Beth Israel Deaconess Medical Center Inc. Carbon monoxide improves outcomes in tissue and organ transplants and suppresses apoptosis
US20040081580A1 (en) * 2002-09-10 2004-04-29 Doug Hole Use of nitric oxide and a device in the therapeutic management of pathogens in mammals
US7531133B2 (en) * 2002-09-10 2009-05-12 Pulmonox Technologies Corporation Use of nitric oxide gas in an extracorporeal circuitry to treat blood plasma
US7274955B2 (en) * 2002-09-25 2007-09-25 Masimo Corporation Parameter compensated pulse oximeter
JP4352315B2 (ja) * 2002-10-31 2009-10-28 日本光電工業株式会社 信号処理方法／装置及びそれを用いたパルスフォトメータ
US7485324B2 (en) * 2003-09-29 2009-02-03 Pulmonox Technologies Corporation Use of exogenous gaseous nitric oxide in the treatment and disinfection of biofilms
WO2005081752A2 (en) 2004-02-09 2005-09-09 Amulet Pharmaceuticals, Inc. Nitric oxide-releasing polymers
US7523752B2 (en) 2005-09-21 2009-04-28 Ino Therapeutics, Llc System and method of administering a pharmaceutical gas to a patient
WO2007124044A2 (en) 2006-04-19 2007-11-01 Transmedics, Inc. Systems and methods for ex vivo organ care
US8420380B2 (en) * 2008-01-31 2013-04-16 Transmedics, Inc. Systems and methods for ex vivo lung care
WO2010076737A1 (en) * 2008-12-31 2010-07-08 Koninklijke Philips Electronics N.V. A method and apparatus for controlling a process of injury therapy
US9216198B2 (en) 2009-03-30 2015-12-22 The Board Of Regents, The University Of Texas System Compositions and medical devices for controlled release of nitric oxide and methods of production thereof
CA2671029A1 (en) 2009-06-30 2010-12-30 James S. Baldassarre Methods of treating term and near-term neonates having hypoxic respiratory failure associated with clinical or echocardiographic evidence of pulmonary hypertension
US20120201906A1 (en) 2009-09-08 2012-08-09 Reynolds James D Novel medical uses for no and no donor compounds
MX378823B (es) 2011-01-06 2025-03-10 Mallinckrodt Hospital Products Ip Ltd Dispositivo y sistema de entrega de gas.
CA2854776C (en) 2011-11-07 2020-08-18 Ino Therapeutics Llc Apparatus and method for monitoring nitric oxide delivery
WO2013181322A1 (en) * 2012-05-31 2013-12-05 Ino Therapeutics Llc Methods of administering nitric oxide to arterial or arterialized blood
MX375330B (es) * 2013-03-13 2025-03-06 Mallinckrodt Hospital Products Ip Ltd Dispositivos y metodos para monitorizar la oxigenacion durante el tratamiento con el suminitro de oxido nitrico.

Also Published As

Publication number Publication date
PT3698630T (pt) 2024-05-31
EP3698630A1 (en) 2020-08-26
CA2931943C (en) 2021-11-30
ES2805366T3 (es) 2021-02-11
FI3698630T3 (fi) 2024-05-24
JP6884190B2 (ja) 2021-06-09
PL3698630T3 (pl) 2024-08-05
US20170215411A1 (en) 2017-08-03
EP3086638B1 (en) 2020-04-22
CA2931943A1 (en) 2015-06-11
MX2021001867A (es) 2021-04-19
US20140272920A1 (en) 2014-09-18
DK3698630T3 (da) 2024-05-21
EP3086638A2 (en) 2016-11-02
US20150093738A1 (en) 2015-04-02
JP6612231B2 (ja) 2019-11-27
EP3698630B1 (en) 2024-03-13
AU2014357412B2 (en) 2018-03-01
AU2018203630B2 (en) 2019-08-29
JP2020033368A (ja) 2020-03-05
AU2018203630A1 (en) 2018-06-21
CA3135254A1 (en) 2015-06-11
AU2019246828B2 (en) 2021-12-02
US11291202B2 (en) 2022-04-05
AU2014357412A1 (en) 2016-06-16
JP2017503762A (ja) 2017-02-02
WO2015084698A3 (en) 2015-11-05
MX381625B (es) 2025-03-12
AU2019246828A1 (en) 2019-11-07
US9629358B2 (en) 2017-04-25
WO2015084698A2 (en) 2015-06-11
CA3135254C (en) 2024-05-14
CA3233961A1 (en) 2015-06-11

Similar Documents

Publication Publication Date Title
MX2016007057A (es) Administracion y monitoreo de oxido nitrico en fluidos ex vivo.
MX2017011595A (es) Kits, dispositivos descartables para reducir el oxígeno y métodos para usarlos.
CL2019000580A1 (es) Sistema de gestión de información relacionada con las diferencias entre los individuos en el tratamiento por dialisis.
CR20160213A (es) Dispositivo para irrigación e insuflación con control de presión dependiente de presión sanguínea
IL270715A (en) Cannula for intravascular blood pump
MX387846B (es) Obturador antimicrobiano para usarse con dispositivos de acceso vascular.
CR20160104A (es) Dispositivo de estabilización de conexión de catéter y procedimientos de uso del mismo
BR112016010103A8 (pt) métodos, kits e dispositivos de suprimento de fármaco osmótico.
MX2022008266A (es) Metodos para el almacenamiento de sangre completa y composiciones de esta.
MX2018011720A (es) Sistemas y metodos intravenosos ergonomicos.
BR112015027758A2 (pt) subconjunto de percurso de fluxo
BR112014011279A2 (pt) suprimento de oxigênio para sistema de perfusão de orgãos
CL2015002747A1 (es) Metodo para la oxigenacion extracorporea de un sujeto; y aparato de incubacion.
MX2022010313A (es) Sistemas y metodos de tratamiento de la sangre.
ES2614881T3 (es) Suspensión de células de mamífero que contienen trehalosa para la prevención de la formación de una embolia pulmonar
WO2015135955A3 (en) Surgical procedure and devices for use therein
EA201491713A1 (ru) Обеспечивающий инъекции порт сосудистого доступа с различимыми метками для идентификации
BR112015022055A2 (pt) gestão de transições de área de cuidado de infusões intravenosas
EP3277338A4 (en) Cannula system with sterile connector, blood pump, and patient harness
BR112015024464A2 (pt) dispositivo de infusão com estrutura em camadas tendo componentes duráveis e descartáveis
FR3058642B1 (fr) Canule et systeme d'oxygenation par membrane extracorporelle comportant une telle canule
MX2015008529A (es) Solucion para conservar conductos vasculares.
AR091977A1 (es) El uso de antitrombina en la oxigenacion de membranas extracorporeas
EP3372262A4 (en) MEDICAL LIQUID ADMINISTRATION DEVICE
Jawan et al. Review of anesthesia in liver transplantation